MRUS 41.85 (-0.57%)
NL0011606264BiotechnologyBiotechnology

Merus (MRUS) Financial Metrics

This table shows a selected set of financial data points of Merus (MRUS). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -3 0 -9.16 1.42B -0.37 43.95M -146.19M -144.3M -154.94M 204.25M
2022 -2.92 0 -5.3 694.9M -0.31 41.59M -157.54M -184.78M -131.19M 147.75M
2021 -1.73 0 -18.39 1.23B -0.19 49.11M -60.5M -113.15M -66.82M 241.44M
2020 -2.92 0 -6 512.86M -0.35 29.94M -81.19M -65M -85.51M 163.08M
2019 -2.28 0 -6.18 340.99M -0.21 31.13M -65.65M -60.27M -55.15M 197.61M
2018 -1.25 0 -11.24 312.01M -0.11 35.75M -50.53M -26.62M -27.76M 164.43M
2017 -4.57 0 -4.25 372.41M -0.56 14.88M -45.75M -73.94M -87.69M 179.57M
2016 -3.75 0 -5.62 279.27M -0.86 1.4M -27.59M -28.76M -49.67M 59.86M
2015 -1.65 0 0 0 -1.18 1.44M -25.29M -24.92M -25.35M 35.92M
2014 -1.37 0 0 0 -1.97 944.84K -17.93M -20.81M -21.17M 2.24M
2013 -0.89 0 0 0 0 260.99K -9.73M -13.24M -13.68M 14.7M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.